$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

중국의 COVID-19 대응을 위한 중의약 활용
Utilization of Traditional Chinese Medicine for COVID-19 in China 원문보기

대한예방한의학회지 = Journal of Society of Preventive Korean Medicine, v.24 no.2, 2020년, pp.1 - 15  

김하늘 (한국한의학연구원 한의학정책연구센터) ,  김창원 (한국한의학연구원 중국사무소) ,  구남평 (한국한의학연구원 중국사무소) ,  이준혁 (한국한의학연구원 한의학정책연구센터) ,  이은희 (한국한의학연구원 한의학정책연구센터) ,  김동수 (한국한의학연구원 한의학정책연구센터)

Abstract ▼ AI-Helper 아이콘AI-Helper

Objectives : The objectives of this study were to investigate why and how China used traditional Chinese medicine as a response to COVID-19 and how its performance was achieved, and to explore ways to utilize traditional Korean medicine in Korea. Methods : We examined the information through governm...

주제어

#COVID-19   #China   #Traditional Chinese medicine   #communicable disease   #communicable diseases control  

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 본 연구는 COVID-19를 대응하기 위한 중국의 중의약 정책 자료를 조사하고 체계적으로 구성하는 것을 목적으로 한다. 중의약 정책 자료 분석에 앞서 중의약 정책을 중국의 COVID-19 진행 상황에 따라 파악하기 위해 중국 COVID-19 진행과정을 우리나라의 COVID-19 진행과정과 비교하여 제시하였다.
  • 특히 감염병 방역에서 한의약의 역할과 활용 방안을 마련한다면 우리나라 방역 체계의 효율성을 높이고 약점을 보완할 수 있을 것으로 생각된다. 본 연구는 중국이 COVID-19를 대응하기 위하여 중의약을 어떻게 활용하였으며, 그 성과는 무엇인지를 정부 자료와 언론 기사 등을 통해 파악하였다. 중국의 중의약 활용 사례는 한의약 활용 방안을 모색하는데 기초적인 아이디어와 근거를 제공해 줄 수 있을 것으로 보인다.
  • 이 통지에서는 먼저 중‧서의 결합 치료가 원활히 이루어질 수 있도록 국가 행정 체계의 거버넌스를 구축할 것을 제시하였다. 구체적으로 각 급 위생건강행정부문은 감염 방역 위원회를 설립할 때 중의약 인사를 참여 하도록 하였으며, 치료 전문가 위원회에도 중의약 전문가를 참여하도록 하였다.
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
감염자의 급격한 확산 어떤 문제들을 야기하는가? 우리나라는 COVID-19 방역에 성공한 국가로 인정받고 있지만, 대구·경북지역의 감염 폭증으로 보건의료 시스템의 혼란을 경험하였다. 감염자의 급격한 확산은 병상의 부족, 의료인력의 피로도 상승을 초래하였으며 이로 인해 경증환자의 대처 미흡, 격리자의 관리 부족 등의 문제로 이어졌다7),8). 따라서 현재 재유행이 예상되고 있는 시점에서 다시 COVID-19의 이어질 대유행을 준비해야 한다.
COVID-19 처음 발생한 날짜와 국가는 무엇인가? 2019년 12월 중국에서 처음 발생한 COVID-19(Coronavirus Disease-19) 바이러스는 빠르게 확산하여 현재 전 세계에서 감염 사례가 확인되고 있다. 세계보건기구(World Health Organization, WHO)의 보고서에 따르면 2020년 7월 20일 현재 14,348,858명이 COVID-19에 감염되었으며, 603,691명이 이로 인해 사망하였다1).
홍콩, 마카오를 포함한 중국에서는 중증급성호흡기증후군로 인하여 몇명의 감염자와 사망자가 발생하였는가? 중국은 2003년 중증급성호흡기증후군(SARS) 대유행을 겪었다. 이로 인해 홍콩, 마카오을 포함해 7천여 명의 감염자와 650여 명의 사망자가 발생했다4). 중국 정부는 SARS 대유행으로 기존 보건의료 시스템만으로 충분한 방역이 이루어지지 못하자 세계보건기구의 관련 전문가들의 지도를 통해 중의약을 활용하였으며5) 눈에 띄는 성과를 거두었다.
질의응답 정보가 도움이 되었나요?

참고문헌 (65)

  1. World Health Organization. Coronavirus disease 2019(COVID-19): situation report - 182. Available from: https://www.who.int/docs/default source/coronaviruse/situation-reports/20200720-covid-19-sitrep-182.pdf?sfvrsn60aabc5c_2. Accessed on July 24, 2020. 

  2. Korea Centers for Disease Control and Prevention. Regular briefing: COVID-19 domestic outbreak status(2020.05.28.). Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn159064220445900.pdf&rs/upload_comm/docu/0015/. Accessed on July 24, 2020. 

  3. Ying Liu, Albert A Gayle, Annelies Wilder-Smith, Joacim Rocklov. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine. 2020: Volume 27, Issue 2:taaa021. 

    상세보기

  4. World Health Organization, Summary table of SARS cases by country, 1 November 2002-7 August 2003. Available from: https://www.who.int/csr/sars/country/2003_08_15/en/. Accessed on July 26, 2020. 

  5. Jang I, Hsing L, Han C. An overview on severe acute respiratory syndrome(SARS) in WHO clinical reports. Korean J, Orient, Int. Med. 2005;26(2):440-452 

  6. World Health Organization. SARS-Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine. Geneva. 2004. 

  7. Korea Centers for Disease Control and Prevention. COVID-19 Response Guidelines (for local governments)-the 7th version. 2020. 

  8. SBS News Press Release. [Daegu Connection] Fifth, self-isolation death...More than 2,000 people are waiting to be hospitalized. Available from: https://news.sbs.co.kr/news/endPage.do?news_idN1005681219. Accessed on July 24, 2020. 

  9. World Health Organization. Coronavirus disease 2019(COVID-19): situation report - 1. Available from: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn20a99c10_4. Accessed on July 24, 2020. 

  10. Association of Korean Medicine News. Operation of the Korean medicine TF to respond to COVID-19, Available from: http://www.akomnews.com/bbs/board.php?bo_tablenews&wr_id37958. Accessed on July 20, 2020. 

  11. Korea Centers for Disease Control and Prevention. Regular briefing: COVID-19 domestic outbreak status(2020.02.24.). 2020. Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn158997091504800.pdf&rs/upload_comm/docu/0015/. Accessed on July 24, 2020. 

  12. The Association of Korean Medicine. Announcement of the Korean medicine recommendations on treatment of COVID-19(the first version), Available from: http://www.akom.org/Home/AkomArticleNews/1098395?NewsType7. Accessed on July 20, 2020. 

  13. Association of Korean Medicine News. Announcement of the first version of Oriental Medicice Clinical Practice Guideline by the Korean Association of Traditional Pulmonary Medicine, Available from: http://akomnews.com/bbs/board.php?bo_tablenews&wr_id38324. Accessed on July 20, 2020. 

  14. Maeil News. Korean medicine doctors came forward to overcome COVID-19 - free presciption after telemedicine, Available from: https://news.imaeil.com/Society/2020030812093281709. Accessed on July 24, 2020. 

  15. State Council of the People's Republic of China. Announcement of the National Health Commission of the People's Republic of China, Available from: http://www.gov.cn/zhengce/zhengceku/2020-01/21/content_5471164.htm. Accessed on July 24, 2020. 

  16. MedSci News. The gorvernment demands intervention in the treatment of COVID-19, Available from: https://m.medsci.cn/article/show_article.do?id9290188231fb. Accessed on July 24, 2020. 

  17. National Health Commission of the People's Republic of China. Guideline on diagnosis and treatment of COVID-19 (4th edition), Available from: http://www.nhc.gov.cn/yzygj/s7652m/202001/7450028ab6084101ae8110f0aaf81271.shtml. Accessed on July 24, 2020. 

  18. State Council of the People's Republic of China. Notice about launch of online services for the epidemic prevention of the Hubei province, Available from: http://www.gov.cn/xinwen/2020-02/27/content_5483977.htm. Accessed on July 24, 2020. 

  19. Korea Centers for Disease Control and Prevention. All-out response based on community response system, Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn157966039194500.pdf&rs/upload_comm/docu/0015/. Accessed on July 24, 2020. 

  20. Ministry of Health and Welfare. Infectious Disease Crisis Alert Level Upgrades to "Orange (Level 3)", Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn158020352565600.pdf&rs/upload_comm/docu/0015/. Accessed on July 24, 2020. 

  21. Korea Centers for Disease Control and Prevention. Approving emergency use of new COVID-19 diagnostic reagents, Available from: https://is.cdc.go.kr/upload_comm/syview/doc.html?fn158079220350200.pdf&rs/upload_comm/docu/0015/. Accessed on July 24, 2020. 

  22. Yonhap News. Counseling and prescription by telephone due to mild cold symptoms are temporary allowed, Available from: https://www.yna.co.kr/view/AKR20200221083651017?input1195m. Accessed on July 24, 2020. 

  23. YTN. Briefing of the Central Disaster and Safety Countermeasures Headquarters on COVID-19 response, Available from: https://www.ytn.co.kr/_ln/0103_202002261122278900. Accessed on July 24, 2020. 

  24. YTN. The government will take an active response so that people will not be treated unfairly, Available from: https://www.ytn.co.kr/_ln/0103_202002271102519073. Accessed on July 24, 2020. 

  25. Association of Korean Medicine News. The Association of Korean Medicine publishes the guideline for telemedicine of Korean medicine, Available from: http://www.akomnews.com/bbs/board.php?bo_tablenews&wr_id38781. Accessed on July 24, 2020. 

  26. National Health Commission of the People's Republic of China. Guideline on diagnosis and treatment of COVID-19 (1st edition), Available from:http://www.nhc.gov.cn/jkj/s3578/202002/34c1c337ef874fa58af58a1717005389.shtml. Accessed on July 24, 2020. 

  27. Beijing News. Ministry of Science and Technology of the People's Republic of China: 16 emergency research projects were launched and some drugs were initially selected, Available from: https://www.sohu.com/a/370580329_114988. Accessed on July 24, 2020. 

  28. National Healthcare Security Administration and the Ministry of Finance. Notice about good health coverage for COVID-19, Available from: http://www.gov.cn/xinwen/2020-01/30/content_5473177.htm. Accessed on July 24, 2020. 

  29. Ministry of Science and Technology of the People's Republic of China. Notice about regulation of COVID-19 drug clinical research in medical institutions, Available from: http://www.most.gov.cn/tztg/202002/t20200225_151897.htm. Accessed on July 24, 2020. 

  30. National Health Commission of the People's Republic of China. Nursing Standards for Medium and Critical Patients of COVID-19, Available from: http://www.nhc.gov.cn/yzygj/s7652m/202003/76bbb3c2b37c498588b2d1a11 ed6772e.shtml. Accessed on July 24, 2020. 

  31. National Health Commission of the People's Republic of China. Plan of COVID-19 control and preventive(6th edition), Available from: http://www.nhc.gov.cn/xcs/zhengcwj/202003/4856d5b0458141fa9f376853224d41d7.shtml. Accessed on July 24, 2020. 

  32. National Administration of Traditional Chinese Medicine. Guidance on the Rehabilitation of Chinese medicine for COVID-19 recovery period, Available from: http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42768/xgzc42774/Document/1675757/1675757.htm. Accessed on Jyly 24, 2020. 

  33. Xinhuanet. Obtain approval for clinical trials of 化？？毒？粒, Available from: http://www.xinhuanet.com/health/2020-03/22/c_1125750050.htm. Accessed on July 24, 2020. 

  34. Law of the People's Republic of China on Traditional Chinese Medicine. Available from: http://fjs.satcm.gov.cn/zhengcewenjian/2018-03-24/2249.html. Accessed on July 20, 2020. 

  35. Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases. Available from: http://www.nhc.gov.cn/fzs/s3576/201808/58d2b24710c14c2f97ae6de5a8059b73.shtml. Accessed on July 20, 2020. 

  36. State Council of the People's Republic of China. A press conference on February 20, 2020, Available from: http://www.nhc.gov.cn/xcs/s3574/202002/526411b8aa6143a487a6827aaa2f40ac.shtml. Accessed on July 24, 2020. 

  37. Chinese Clinical Trial Registry, Available from: http://www.chictr.org.cn/index.aspx, Accessed on July 24, 2020. 

  38. China Food and Drug Network News. Two cases of herbal medicine's hospital preparations for COVID-19 prevention and treatment have been approved in Sanxi Province, Available from: http://www.cqn.com.cn/cj/content/2020-02/17/content_8220883.htm. Accessed on July 24, 2020. 

  39. Soju. Hospital preparation for COVID-19 of Pneumonia No. 1 and Qianli Pneumonia No. 1 have been approved in Hubei Province, Available from: https://www.sohu.com/a/375548592_260616. Accessed on July 24, 2020. 

  40. Hubei Drug Administration. Hubei's first herbal medicine preparation for pneumonia caused by the new coronavirus infection, Available from: http://fda.hubei.gov.cn/fbjd/dtyw/202002/t20200219_2139257.shtml. Accessed on July 24, 2020. 

  41. Yunnan Daily. Preparing for approval of seven medical institutions in Yunnan Province, Available from: http://yn.people.com.cn/n2/2020/0218/c378439-33804876.html. Accessed on July 24, 2020. 

  42. National Administration of Traditional Chinese Medicine. Tujie Quwen Granules has passed an emergency approval and application for herbal medicine from Guangdong Medical Center, Available from: http://www.satcm. gov.cn/xinxifabu/gedidongtai/2020-02-06/12855.html. Accessed on July 24, 2020. 

  43. China Broadcasting Network, Chengdu. Sichuan approves the use of three kinds of hospital preparations in 205 designated hospitals in the province, Available from: http://news.cnr.cn/native/city/20200212/t20200212_524971992.shtml. Accessed on July 24, 2020. 

  44. Chinese Medicine Network. When the country is in trouble, the Chinese medicine doctors are responsible and they rush to the front, Available from: http://www.tmbos.com/index/article/view/id/14017.html. Accessed on July 24, 2020. 

  45. Ministry of Science and Technology of the People's Republic of China. Local science and technology departments take active action to provide scientific and technical support for the prevention and control of infectious diseases, Available from: http://www.most.gov.cn/dfkj/dfkjyw/dfzxdt/202001/t20200130 _151268.htm. Accessed on July 24, 2020. 

  46. National Administration of Traditional Chinese Medicine. Step-by-step progress has been made in the screening of effective herbal medicine prescriptions, and clinical observations in the experimental provinces shows that the total effectiveness of the treatment for clearing lung can be more than 90, Available from: http://bgs.satcm.gov.cn/gongzuodongtai/2020-02-06/12866.html. Accessed on July 24, 2020. 

  47. Ministry of Science and Technology of the People's Republic of China.Tianjin University of Traditional Chinese Medicine actively carried out the research and clinical application of TCM to control COVID-19, Available from: http://www.most.gov.cn/dfkj/tj/zxdt/202002/t20200228_152017.htm. Accessed on July 24, 2020. 

  48. National Intellectual Property Administration, PRC. Patent information on Chinese Medicine for the prevention and control of COVID-19, Available from: http://www.sipo.gov.cn/zscqgz/1146598.htm. Accessed on July 24, 2020. 

  49. National Administration of Traditional Chinese Medicine. Available from: http://www.satcm.gov.cn/a/zcwj/.Accessed on 6 May, 2020. 

  50. National Administration of Traditional Chinese Medicine. Notice about Chinese medicine prevention of COVID-19, Available from: http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-12/13036.html. Accessed on July 24, 2020. 

  51. National Administration of Traditional Chinese Medicine. Notice about combination Chinese and Western medicine for COVID-19, Available from: http://yzs.satcm.gov.cn/zhengcewenjian/2020-02-13/13053.html. Accessed on July 24, 2020. 

  52. National Administration of Traditional Chinese Medicine. Notice of establishment of Chinese and Western medicine cooperative system in preventive treatment of infectious diseases, such as COVID-19, Available from: http://www.xinhuanet.com/health/2020-02/12/c_1125563760.htm. Accessed on July 24, 2020. 

  53. National Administration of Traditional Chinese Medicine. Notice about strengthening information for support of Chinese medicines prevention for COVID-19, Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/09/content_5476446.htm. Accessed July on 24, 2020. 

  54. South China Morning Post. China unveils targets for 2015: Li Keqiang's speech as it happened. South China Morning Post, Available from: https://www.scmp.com/news/china/article/1729846/live-li-keqiang-unveils-chinas-annual-work-report. Accessed on July 24, 2020. 

  55. CCTV health. National Administration of Traditional Chinese Medicine: Chinese medicine accounted for 85.2% of Chinese national treatment, Available from: http://health.cnr.cn/jkgdxw/20200219/t20200219_524981526.shtml. Accessed on July 24, 2020. 

  56. Korea Institute of Oriental Medicine. Chinese medicine trends related to COVID-19 in China. 2020. 

  57. Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020. Published online March 11, 2020:323(15):1499-1500. 

    상세보기 crossref

  58. Greenhalgh T(b), Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020:368. 

  59. Shen Ai-ming, Zhang Wei, Wu Zhuo, Wang Wen-long, Hua Jia-jia. TCM Theory analysis of Qing-Fei-Pai-Du-Tang in treating COVID-19. Liaoning Journal of Traditional Chinese Medicine. 2020. 

  60. 路志正,路喜善."？肺排毒？"彰？中？？抗疫？效？自信. Journal of Traditional Chinese Medicine. 2020. 

  61. Ang L, Lee HW, Choi JY, Zhang J, Lee MS. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integrative Medicine Research 2020;9(2). 

  62. National Health Commission of the People's Republic of China. Notice on the issuance of the new 7th version of the COVID-19 Diagnosis and Treatment Guideline. 2020. 

  63. Gras G. Use of telemedicine in the management of infectious diseases. Medecine et maladies infectieuses. 2018:48:231-237. 

    상세보기 crossref

  64. Burnham JP, Fritz SA, Yaeger LH, Colditz GA. Telemedicine Infectious Diseases Consultations and Clinical Outcomes: A Systematic Review. Open Forum Infect Dis. 2019:5;6(12):ofz517. 

    상세보기 crossref

  65. Park SC, Park YC. Mental Health Care Measures in Response to the 2019 Novel Coronavirus Outbreak in Korea. Psychiatry Investigation. 2020:17(2):85-86. 

    상세보기 crossref

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로